https://arxiv.universalpublishings.com/id/eprint/55853 2026-05-26T15:48:07Z info:eu-repo/semantics/descriptiveMetadata https://arxiv.universalpublishings.com/id/eprint/55853/ POLYCYSTIC OVARIAN SYNDROME AND MENOPAUSE Gaffarovna, Nomurodova Shahnoza Sattarovna, Hamidova Manzura Norkuchkarovich, Imamov Elmurod Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies, which occurs in 4–21% of women during reproductive age and is the most common form of hyperandrogenism [1, 2]. The clinical manifestations of PCOS are diverse, and most of them accompany a woman throughout her life, varying depending on age, ethnicity, constitutional and other factors. Due to the increase in average life expectancy, modern women spend quite a long period in peri- and postmenopause, which determines the need to monitor the clinical manifestations of PCOS, its long-term complications, as well as the features of the onset and course of age-associated diseases in this endocrinopathy [3–6]. "Research Science and Innovation house" LLC 2023-12-17 Maqola NonPeerReviewed Gaffarovna, Nomurodova Shahnoza, Sattarovna, Hamidova Manzura, Norkuchkarovich, Imamov Elmurod (2023) POLYCYSTIC OVARIAN SYNDROME AND MENOPAUSE. Journal of Universal Science Research. https://universalpublishings.com/index.php/jusr/article/view/3390 oai:ojs.pkp.sfu.ca:article/3390 oai:ojs.pkp.sfu.ca:article/3390 info:eu-repo/semantics/humanStartPage